A proposed policy allowing hospitals to directly import advanced medical equipment could significantly transform India’s healthcare supply chain, reducing dependence on traditional procurement channels and accelerating access to high-end medical technology. The move is being viewed as a potential game changer for hospitals, medical device manufacturers, distributors, and healthcare providers across the country.
Under the proposal being considered by the country’s regulatory authorities, hospitals may be permitted to import sophisticated medical devices directly from global manufacturers. The initial list reportedly includes around 80 categories of equipment such as MRI scanners, CT scanners, PET-CT systems, mammography units, gamma cameras, and other advanced diagnostic and imaging technologies. The objective is to simplify procurement processes and improve the availability of cutting-edge healthcare infrastructure.
Supporters of the proposal argue that direct imports could shorten procurement timelines, reduce intermediary costs, and enable healthcare institutions to access the latest technologies more quickly. Hospitals, particularly large tertiary-care and specialty centres, often face delays in acquiring advanced equipment through conventional supply chains involving multiple distributors and approval layers. A streamlined import framework could help address these challenges while improving patient care and diagnostic capabilities.
The proposal comes at a time when India’s medical devices sector is undergoing rapid transformation. Although the country’s healthcare market continues to expand, dependence on imported high-technology medical devices remains substantial, especially in segments such as diagnostic imaging, oncology equipment, implants, and critical-care systems. Industry experts note that advanced technologies are still largely sourced from overseas manufacturers despite ongoing efforts to strengthen domestic production.
However, the suggested policy has also triggered debate within the medical technology ecosystem. Domestic manufacturers fear that easier import pathways could increase competition from foreign suppliers and potentially slow the growth of local manufacturing initiatives. India has invested heavily in promoting indigenous production through policy measures such as the Production Linked Incentive (PLI) scheme, which seeks to reduce import dependence and build a globally competitive medical devices industry.
Industry stakeholders stress that while access to advanced technologies is important, policymakers must maintain a balance between encouraging imports and nurturing domestic innovation. Manufacturers argue that long-term self-reliance in medical technology will require sustained support for local research, development, and production capabilities. At the same time, healthcare providers emphasize the need for affordable and timely access to world-class equipment that can enhance treatment outcomes.
The proposed framework also reflects broader discussions around trade liberalisation and healthcare infrastructure development. Recent policy conversations on medical device imports, trade agreements, and regulatory reforms indicate a growing focus on integrating India more deeply into global healthcare supply chains while ensuring quality and safety standards are maintained.
If implemented, the direct import policy could alter procurement practices across the healthcare sector by giving hospitals greater control over equipment sourcing. While the final contours of the framework are still under consideration, the proposal has already sparked discussions about its potential impact on costs, competition, innovation, and the future structure of India’s medical devices market.
As India seeks to strengthen healthcare delivery and expand access to advanced medical technologies, the outcome of this policy debate could play a crucial role in shaping the next phase of growth for the country’s healthcare ecosystem and supply chain network.
